glp 1 ra stands for GLP-1 receptor agonism: a transformative approach managing type-2 diabetes and obesity | Saudi Pharmaceutical Journal Consensus Recommendations on GLP-1 RA

A pooled analysis of three major cardiovascular outcome trials (CVOTs) studying 15,820 patients with T2D treated with liraglutide or semaglutide reported a significantly lower hazard ratio ([HR] = 0.47) for subsequent dementia diagnosis compared to placebo, over a median follow-up of 3.61 years

Monami M, Nreu B, Scatena A, Giannini S, Andreozzi F, Sesti G, Mannucci E

While celebrity-endorsed supplements often warrant skepticism, the formulation of Lemme GLP-1 Daily is actually both powerful and novel, combining the appetite-supporting effects of Supresa with two other ingredients that target different aspects of metabolic health

Wang, T

We help you set realistic goals, celebrate your successes, and stay committed to your health journey, even in the face of setbacks

How might combining liraglutide therapy with exercise amplify its benefits, and what implications does this have for developing comprehensive treatment plans for patients with obesity or Type 2 diabetes